381 related articles for article (PubMed ID: 8372514)
1. Engineering mouse monoclonal antibodies for cancer immunotherapy.
Orlandi R
Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
[No Abstract] [Full Text] [Related]
2. Recombinant chimeric monoclonal antibodies.
Morrison SL; Schlom J
Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
[No Abstract] [Full Text] [Related]
3. The construction of a mouse/human chimeric antibody against human breast cancer cells.
Meulemans E; Vandevyver C; Volckaert G; Raus J
Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
[No Abstract] [Full Text] [Related]
4. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
Lewis AP; Crowe JS
Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
[No Abstract] [Full Text] [Related]
5. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
[TBL] [Abstract][Full Text] [Related]
6. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
Kaulen H; Seemann G; Bosslet K; Schwaeble W; Dippold W
Year Immunol; 1993; 7():106-9. PubMed ID: 8372499
[No Abstract] [Full Text] [Related]
7. Immunogenicity of engineered antibodies.
Hwang WY; Foote J
Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
[TBL] [Abstract][Full Text] [Related]
8. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities.
Gillies SD; Wesolowski JS
Hum Antibodies Hybridomas; 1990; 1(1):47-54. PubMed ID: 2129419
[TBL] [Abstract][Full Text] [Related]
9. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
10. [Transgenesis and humanization of murine antibodies].
Cogné M; Duchez S; Pascal V
Med Sci (Paris); 2009 Dec; 25(12):1149-54. PubMed ID: 20035696
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic antibody gene transfer.
Marasco WA
Nat Biotechnol; 2005 May; 23(5):551-2. PubMed ID: 15877069
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
13. Engineering therapeutic monoclonal antibodies.
Liu XY; Pop LM; Vitetta ES
Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
[TBL] [Abstract][Full Text] [Related]
15. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic antibodies and antibody fusion proteins.
Rohrbach P; Broders O; Toleikis L; Dübel S
Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
[No Abstract] [Full Text] [Related]
17. Construction and characterization of a new chimeric antibody against HER2.
Amiri MM; Jeddi-Tehrani M; Kazemi T; Bahadori M; Maddah M; Hojjat-Farsangi M; Khoshnoodi J; Rabbani H; Shokri F
Immunotherapy; 2013 Jul; 5(7):703-15. PubMed ID: 23829622
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibodies: magic bullets hit the target.
Gura T
Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
[No Abstract] [Full Text] [Related]
20. From laboratory to clinic: the development of an immunological reagent.
Bright S; Adair J; Secher D
Immunol Today; 1991 Apr; 12(4):130-4. PubMed ID: 2059313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
